These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 20061077)

  • 1. Degenerative parkinsonism in patients with psychogenic parkinsonism: A dopamine transporter imaging study.
    Felicio AC; Godeiro-Junior C; Moriyama TS; Shih MC; Hoexter MQ; Borges V; Silva SM; Aguiar Pde C; Andrade LA; Bressan RA; Ferraz HB
    Clin Neurol Neurosurg; 2010 May; 112(4):282-5. PubMed ID: 20061077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased dopamine transporter density in Parkinson's disease patients with Social Anxiety Disorder.
    Moriyama TS; Felicio AC; Chagas MH; Tardelli VS; Ferraz HB; Tumas V; Amaro-Junior E; Andrade LA; Crippa JA; Bressan RA
    J Neurol Sci; 2011 Nov; 310(1-2):53-7. PubMed ID: 21783205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transporter binding in chronic manganese intoxication.
    Huang CC; Weng YH; Lu CS; Chu NS; Yen TC
    J Neurol; 2003 Nov; 250(11):1335-9. PubMed ID: 14648150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.
    Carbon M; Ma Y; Barnes A; Dhawan V; Chaly T; Ghilardi MF; Eidelberg D
    Neuroimage; 2004 Apr; 21(4):1497-507. PubMed ID: 15050574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.
    Weng YH; Yen TC; Chen MC; Kao PF; Tzen KY; Chen RS; Wey SP; Ting G; Lu CS
    J Nucl Med; 2004 Mar; 45(3):393-401. PubMed ID: 15001678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging.
    Huang WS; Lin SZ; Lin JC; Wey SP; Ting G; Liu RS
    J Nucl Med; 2001 Sep; 42(9):1303-8. PubMed ID: 11535717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
    Bor-Seng-Shu E; Pedroso JL; Felicio AC; de Andrade DC; Teixeira MJ; Braga-Neto P; Batista IR; Barsottini OG; Borges V; Ferraz HB; Shih MC; Bressan RA; de Andrade LA; Walter U
    Parkinsonism Relat Disord; 2014 May; 20(5):477-81. PubMed ID: 24629800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.
    Weintraub D; Newberg AB; Cary MS; Siderowf AD; Moberg PJ; Kleiner-Fisman G; Duda JE; Stern MB; Mozley D; Katz IR
    J Nucl Med; 2005 Feb; 46(2):227-32. PubMed ID: 15695780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.
    Brunswick DJ; Amsterdam JD; Mozley PD; Newberg A
    Am J Psychiatry; 2003 Oct; 160(10):1836-41. PubMed ID: 14514499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1.
    Hsiao MC; Lin KJ; Liu CY; Tzen KY; Yen TC
    Schizophr Res; 2003 Dec; 65(1):39-46. PubMed ID: 14623373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.
    Tzen KY; Lu CS; Yen TC; Wey SP; Ting G
    J Nucl Med; 2001 Mar; 42(3):408-13. PubMed ID: 11337515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.
    Roselli F; Pisciotta NM; Perneczky R; Pennelli M; Aniello MS; De Caro MF; Ferrannini E; Tartaglione B; Defazio G; Rubini G; Livrea P
    Mov Disord; 2009 Oct; 24(14):2097-103. PubMed ID: 19705471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients.
    Hsiao IT; Weng YH; Lin WY; Hsieh CJ; Wey SP; Yen TC; Kung MP; Lu CS; Lin KJ
    Nucl Med Biol; 2014 Apr; 41(4):322-9. PubMed ID: 24503330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
    Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
    Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroimaging of the dopamine transporter in Parkinsons disease: first study using [99mTc]-TRODAT-1 and SPECT in Brazil].
    Shih MC; Amaro E; Ferraz HB; Hoexter MQ; Goulart FO; Wagner J; Lin LF; Fu YK; Mari JJ; de Lacerda AL; Tufik S; Bressan RA
    Arq Neuropsiquiatr; 2006 Sep; 64(3A):628-34. PubMed ID: 17119808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset-related subtypes of Parkinson's disease differ in the patterns of striatal dopaminergic dysfunction: A positron emission tomography study.
    Liu SY; Wu JJ; Zhao J; Huang SF; Wang YX; Ge JJ; Wu P; Zuo CT; Ding ZT; Wang J
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1448-53. PubMed ID: 26559130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.
    Huang WS; Chiang YH; Lin JC; Chou YH; Cheng CY; Liu RS
    J Nucl Med; 2003 Jul; 44(7):999-1005. PubMed ID: 12843212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease.
    Lynch DR; Mozley PD; Sokol S; Maas NM; Balcer LJ; Siderowf AD
    Mov Disord; 2003 Jul; 18(7):804-12. PubMed ID: 12815660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus.
    Vriend C; Raijmakers P; Veltman DJ; van Dijk KD; van der Werf YD; Foncke EM; Smit JH; Berendse HW; van den Heuvel OA
    J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):159-64. PubMed ID: 23813742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Real-World Study of Cerebral 99mTc-TRODAT-1 Single-Photon Emission Computed Tomography (SPECT) Imaging of the Dopamine Transporter in Patients with Parkinson Disease from a Tertiary Hospital in Brazil.
    Arjona M; Toldo JMP; Queiroz NC; Pedroso JL; Neto GCC; Barsottini OGP; Felicio AC
    Med Sci Monit; 2020 Dec; 26():e925130. PubMed ID: 33361743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.